Keywords: ucb, updates, progress, keppra, xyzal, new, drugs

UCB updates R&D progress of Keppra, Xyzal and new drugs

Article | 19 May 2003

Print This

Belgian pharmaceuticals and chemicals company UCB has outlined its R&D progress in its 2002 annual report, in which it notes ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in